Time-point analysis showed rapid decay of EdU signal from pSmad2-positive cells, with no significant loss of signal from ID1-positive cells, consistent with a divergence in cell cycle entry between BMP-activated and TGF-β-activated glioma cells. The gene discussed is TGFB1; the disease is central nervous system cancer.